Related Experiment Video

Updated: Jun 19, 2026

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

Pediatric sepsis: actions to decrease sepsis in children

Giuseppe A Marraro1

  • 1Anesthesia and Intensive Care Department & Pediatric Intensive Care Unit, Fatebenefratelli and Ophthalmiatric Hospital, University of Milan, Milan, Italy. gmarraro@picu.it

Expert Review of Anti-Infective Therapy
|October 7, 2009
PubMed

Insights

The European Society of Pediatric and Neonatal Intensive Care annual meeting focused on sepsis. Experts discussed optimal supportive, preventive, and therapeutic strategies for sepsis treatment.

Area of Science:

  • Pediatric and Neonatal Intensive Care Medicine
  • Infectious Diseases
  • Critical Care

Background:

  • The European Society of Pediatric and Neonatal Intensive Care (ESPNIC) convened its annual meeting in Verona, Italy, June 14-17, 2009.
  • The congress gathered approximately 1000 international participants, including physicians and nurses, from 84 countries.

Purpose of the Study:

  • To foster discussion and exchange of opinions among experts on current research in pediatric and neonatal intensive care.
  • To explore future research directions for identifying optimal supportive, preventive, and therapeutic strategies for sepsis in neonates and children.

Main Methods:

  • The meeting featured a wide range of scientific topics related to sepsis.
  • Discussions included lectures, oral presentations, and poster sessions dedicated to sepsis and its management.

Main Results:

  • High-level scientific topics concerning sepsis were presented, generating significant interest and discussion among attendees.
  • The congress facilitated the exchange of expert opinions on advancing sepsis research and treatment strategies.

Conclusions:

  • The annual meeting served as a crucial platform for advancing the understanding and treatment of sepsis in pediatric and neonatal intensive care settings.
  • Continued research and collaboration are essential for developing optimal strategies to combat sepsis in critically ill infants and children.

More Related Videos

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever: